Surgical Quality Improvement

Total Hip Arthroplasty Outcomes

Total Hip Arthroplasty ACS NSQIP Outcomes

January 1, 2024 – December 31, 2024

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total hip arthroplasty ACS NSQIP performance benchmarked against 491 participating sites.

Total Hip Arthroplasty (491 sites)NObservedExpected
30 Day Mortality2500.00%0.39%
30 Day Morbidity2503.60%4.17%
Cardiac2500.40%0.20%
Pneumonia2500.00%0.35%
Unplanned Intubation2500.00%0.10%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus2500.80%0.58%
Renal Failure2500.00%0.31%
Urinary Tract Infection (UTI)2500.80%0.74%
Surgical Site Infection (SSI)2501.60%1.58%
Sepsis2500.40%0.41%
Unplanned Reoperation2502.40%2.58%
Unplanned Readmission2504.40%4.64%

American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.